
Aurora Cannabis ACB
€ 2.87
-2.48%
Geschäftsbericht 2025
hinzugefügt 11.04.2026
Aurora Cannabis DIO 2011-2026 | ACB
DIO Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 1.35 K | 2.14 K | -1.99 K | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.14 K | -1.99 K | 500 |
DIO anderer Aktien in der Arzneimittelhersteller
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Assertio Holdings
ASRT
|
322 | $ 18.03 | 0.06 % | $ 115 M | ||
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
OrganiGram Holdings
OGI
|
2.83 K | $ 1.39 | -0.71 % | $ 402 M | ||
|
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.16 | 2.27 % | $ 44.4 M | ||
|
Cronos Group
CRON
|
221 | $ 2.56 | -0.68 % | $ 1.32 B | ||
|
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.61 | 0.18 % | $ 2.05 B | ||
|
Harrow Health
HROW
|
65.1 | $ 36.59 | 1.84 % | $ 1.35 B | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.02 | -2.38 % | $ 110 M | ||
|
Tilray
TLRY
|
170 | $ 6.41 | -2.51 % | $ 3.96 B | ||
|
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Veru
VERU
|
179 | $ 2.38 | - | $ 321 M | ||
|
Viatris
VTRS
|
140 | $ 13.52 | 0.33 % | $ 16.2 B | ||
|
Evolus
EOLS
|
71.3 | $ 4.33 | 1.41 % | $ 279 M | ||
|
Emergent BioSolutions
EBS
|
176 | $ 8.0 | 0.5 % | $ 410 M | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.38 | -0.21 % | $ 313 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 24.14 | 1.47 % | $ 1.12 B | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
165 | $ 0.68 | 0.35 % | $ 2.93 M | ||
|
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.38 | 4.49 % | $ 2.95 M | ||
|
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
29.2 | $ 0.91 | 0.05 % | $ 32.7 M | ||
|
China Pharma Holdings
CPHI
|
166 | $ 0.65 | - | $ 2.79 M | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.11 | 1.69 % | $ 24.4 M |